Future research will focus on determining the causal role of NPC1 in promoting HCC malignancy and assessing the therapeutic potential of its inhibition, thus offering essential functional proof to confirm NPC1 as a therapeutic target. Here, NPC1 is linked to hepatocellular carcinoma.